These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Celecoxib and rofecoxib. The role of COX-2 inhibitors in dental practice. Moore PA; Hersh EV J Am Dent Assoc; 2001 Apr; 132(4):451-6. PubMed ID: 11315375 [TBL] [Abstract][Full Text] [Related]
13. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs. Atkinson HG Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146 [No Abstract] [Full Text] [Related]
14. The prevalence of cardiorenal risk factors in patients prescribed nonsteroidal anti-inflammatory drugs: data from managed care. Harley C; Wagner S Clin Ther; 2003 Jan; 25(1):139-49. PubMed ID: 12637116 [TBL] [Abstract][Full Text] [Related]
15. Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs. Perazella MA; Tray K Am J Med; 2001 Jul; 111(1):64-7. PubMed ID: 11448662 [No Abstract] [Full Text] [Related]
16. Summaries for patients. The cost-effectiveness of cyclooxygenase-2 inhibitors for treating chronic arthritis. Ann Intern Med; 2003 May; 138(10):I39. PubMed ID: 12755582 [No Abstract] [Full Text] [Related]
17. Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. Patrono C; Patrignani P; García Rodríguez LA J Clin Invest; 2001 Jul; 108(1):7-13. PubMed ID: 11435450 [No Abstract] [Full Text] [Related]
18. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2]. Patrignani P Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604 [No Abstract] [Full Text] [Related]
19. A new class of COX-2 inhibitors offer an alternative to NSAIDS in pain management after spinal surgery. Reuben SS Spine (Phila Pa 1976); 2001 Jul; 26(13):1505-6. PubMed ID: 11458162 [No Abstract] [Full Text] [Related]
20. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice. Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]